Low sexual desire in women responds to a wider range of interventions than most people realize, but the catch is that no single fix works for everyone because desire itself is shaped by hormones, brain chemistry, relationship dynamics, stress, sleep, and even how you feel about your own body. The evidence points to several approaches with genuine clinical support, from testosterone therapy and mindfulness-based programs to sleep hygiene and pelvic floor training. What actually works for you depends on identifying which factors are pulling your desire down in the first place.
Why Desire Has Both a Gas Pedal and a Brake
A useful way to think about sexual desire is that your brain runs two systems simultaneously: one that responds to sexual cues and ramps up arousal, and one that monitors for reasons to shut arousal down. Researchers call this the Dual Control Model, and reviews of the literature consistently find that people vary in how sensitive each system is. Some women have a responsive accelerator but an overactive brake; others have the opposite pattern.
The accelerator side is driven by neurotransmitters like dopamine, norepinephrine, and oxytocin, while the brake side leans heavily on serotonin, opioids, and endocannabinoids.1PubMed. Understanding the Role of Serotonin in Female Hypoactive Sexual Desire Disorder and Treatment Options This matters practically because many things that lower desire aren’t weakening your accelerator; they’re slamming the brake. Stress, certain medications, pain during sex, negative body image, and relationship tension all activate the inhibitory side. That means “increasing sex drive” often isn’t about adding something new. It’s about figuring out what’s suppressing what was already there and removing it.
Testosterone Therapy
Testosterone gets the most attention as a hormonal treatment for low desire, and the evidence, while real, is more modest than headlines suggest. In postmenopausal women, large randomized trials using a transdermal testosterone patch delivering 300 micrograms per day found a meaningful increase in satisfying sexual episodes compared to placebo, along with improvements in desire and reductions in distress.2PubMed. Testosterone for low libido in postmenopausal women not taking estrogen A 2025 systematic review confirmed that these improvements are consistent across multiple large-scale trials in postmenopausal women.3PubMed. Testosterone therapy for female sexual dysfunction: a systematic review of the literature demonstrating outcomes in premenopausal and postmenopausal women
The honest caveat is that the effect, while statistically clear, is small in absolute terms, and long-term safety data remain limited.4PubMed Central. Testosterone therapy for women with low sexual desire: a position statement from the Brazilian Society of Endocrinology and Metabolism No testosterone product is currently approved for women in the United States, though some clinicians prescribe compounded formulations or off-label men’s products at lower doses. If you’re considering this route, a conversation with an endocrinologist or sexual medicine specialist is worth the effort, because dose and delivery method matter and blood monitoring helps catch side effects early.
When Menopause Changes the Landscape
Menopause introduces a specific physiological challenge beyond the general testosterone conversation. Falling estrogen levels cause vaginal tissue to thin and dry out, which can make intercourse painful. That pain creates a negative feedback loop: sex hurts, so your brain learns to put the brakes on desire to avoid the discomfort. Estrogen therapy, applied locally as a vaginal cream or ring, directly targets this problem by restoring lubrication and tissue health, which can indirectly improve desire by making sex enjoyable again.5PubMed Central. Increasing women’s sexual desire: The comparative effectiveness of estrogens and androgens
This is worth highlighting because many women attribute their entire drop in desire to “getting older” or “hormones” when the real problem is pain they’ve normalized or learned to anticipate. Treating the vaginal dryness alone won’t necessarily restore desire to premenopausal levels, but it removes one of the most common physical brakes. If you’re postmenopausal and experiencing both low desire and discomfort during sex, addressing the discomfort first sometimes resolves both.
Prescription Medications for Low Desire
Two FDA-approved drugs specifically target low sexual desire in premenopausal women. They work differently and have different practical profiles.
Flibanserin is a daily oral pill that adjusts the balance of serotonin and dopamine in the brain. In the pivotal trials, it increased the number of satisfying sexual events and improved desire-related measures, though it did not significantly change daily self-reported peak desire levels.6PubMed. Flibanserin Efficacy and Safety in Premenopausal Women With Generalized Acquired Hypoactive Sexual Desire Disorder Its most common side effects are dizziness, sleepiness, and nausea, and it cannot be combined with alcohol. The daily dosing means it takes weeks to reach its full effect, and the improvements are gradual rather than dramatic.
Bremelanotide takes a completely different approach. It’s a self-administered injection given on demand before anticipated sexual activity, and it works through melanocortin receptors thought to activate excitatory brain pathways.7PubMed. An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder The on-demand format appeals to women who don’t want to take a daily pill, though the injection itself and the nausea it sometimes causes are barriers for some.8PubMed Central. Clinical trial evidence on emerging pharmacological therapies for hypoactive sexual desire disorder in women: a systematic review and analysis of completed studies registered on ClinicalTrials.gov
Neither drug produces a sudden surge of lust. The improvements in clinical trials, while consistent, tend to be modest. But for women who have clinically diagnosed low desire that causes genuine distress, even a modest improvement can meaningfully shift quality of life. These drugs are not designed for, and haven’t been tested in, women whose desire is simply lower than they’d prefer but not distressing.
Medications That Kill Desire and What to Do About Them
Before adding anything new, it’s worth checking whether something you’re already taking is the problem. SSRIs and similar antidepressants are among the most common culprits. Serotonin is a key inhibitory signal for sexual desire, so drugs that boost serotonin levels predictably dampen the accelerator while strengthening the brake.1PubMed. Understanding the Role of Serotonin in Female Hypoactive Sexual Desire Disorder and Treatment Options
One well-studied workaround is adding bupropion, which works on dopamine and norepinephrine rather than serotonin. In a randomized, placebo-controlled trial of women with SSRI-induced sexual dysfunction, those who added sustained-release bupropion showed substantially higher sexual function scores after twelve weeks compared to placebo.9PubMed. Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study Switching to bupropion entirely (where appropriate for the underlying depression or anxiety) is another option some clinicians explore.
Oral contraceptives are a subtler but widespread contributor. The pill raises levels of a protein called sex hormone-binding globulin (SHBG), which binds to testosterone and makes it unavailable. One study found that women currently using oral contraceptives had SHBG levels roughly four times higher than women who had never used them. More striking, women who had stopped the pill still had elevated SHBG compared to never-users, even months after discontinuing.10PubMed. Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction Not every woman on the pill notices a desire drop, but if your low desire coincides with starting hormonal contraception, the connection is worth exploring with your prescriber. Non-hormonal options like the copper IUD or barrier methods sidestep this entirely.
Mindfulness-Based Therapy
This is where the evidence surprised researchers. Mindfulness-based group therapy, typically run over several weekly sessions, has shown significant improvements not just in sexual desire but also in arousal, lubrication, satisfaction, and overall sexual functioning.11PubMed. Group mindfulness-based therapy significantly improves sexual desire in women A systematic review of mindfulness interventions and sexuality confirmed these gains across multiple study designs and populations, including women with diagnosed low desire and cancer survivors.12PubMed Central. Mindfulness-based intervention and sexuality: a systematic review
The mechanism makes sense when you consider the brake-and-accelerator model. Many women with low desire aren’t lacking the capacity for arousal; they’re mentally elsewhere during sexual situations, distracted by stress, self-criticism, or the mental to-do list. Mindfulness trains attention back toward physical sensation and present-moment awareness, which effectively takes the foot off the brake. The programs that have been studied typically combine mindfulness meditation with some cognitive-behavioral elements and psychoeducation about desire. If the idea of meditation feels vague or unserious, it’s worth knowing that the effect sizes in these studies are comparable to or better than what pharmaceutical trials report.
Body Image, Self-Objectification, and the Mental Brake
How you feel about your body during sex has a measurable impact on desire and arousal. Research in young adult women found that dissatisfaction with one’s body predicted lower desire and arousal, and that feeling others view your body negatively had a similar effect.13PubMed Central. The Relationship Between Body Image and Domains of Sexual Functioning Among Heterosexual, Emerging Adult Women Negative thoughts about appearance during a sexual encounter specifically predicted lower arousal and more difficulty reaching orgasm.
This extends to a broader pattern called self-objectification, where women habitually monitor their appearance from an outsider’s perspective. Studies in both Israeli and American women found a clear link between self-objectification and sexual dysfunction.14European Journal of Social Psychology. Self‐objectification and sexual dysfunction among women: Testing and extending objectification theory The pathway seems to run through body shame and body self-consciousness during sex, which in turn reduce sexual satisfaction.15PubMed. Self-objectification, body self-consciousness during sexual activities, and sexual satisfaction in college women
This isn’t a problem you solve by simply deciding to feel better about your body. But it does help to recognize that the mental energy spent monitoring how you look during sex is directly competing with the attention needed to register pleasure. This is one reason mindfulness-based approaches work as well as they do: they redirect attention from self-surveillance toward physical sensation. Cognitive-behavioral therapy that specifically addresses body image distortions during sexual activity can also help, and some sex therapists integrate both approaches.
Sleep, Stress, and the Basics That Get Overlooked
Sleep is rarely the first thing women think of when desire drops, but a pilot study tracking daily sleep and sexual behavior found that each additional hour of sleep was associated with a 14% increase in the odds of engaging in partnered sexual activity the next day, and longer sleep predicted higher next-day desire.16PubMed. The impact of sleep on female sexual response and behavior: a pilot study This is a single study, so the specific numbers deserve caution, but the direction of the finding aligns with what sleep researchers know about hormonal regulation and cognitive function. Chronic sleep deprivation raises cortisol, impairs mood, and leaves less mental bandwidth for anything that isn’t immediately urgent. Desire doesn’t stand a chance against exhaustion.
Speaking of cortisol: women reporting high chronic stress show significantly elevated cortisol levels compared to women with average stress.17PubMed Central. Chronic stress and sexual function in women Cortisol is part of the body’s threat-response system, and when it stays elevated, it signals the brain to prioritize survival over reproduction. This isn’t a character flaw or a failure of effort. Your neurochemistry is doing exactly what it evolved to do when the environment feels threatening or overwhelming. Stress reduction strategies, whether therapy, exercise, schedule changes, or delegating responsibilities, aren’t just nice-to-haves. For some women, they’re the single most effective intervention for low desire.
Exercise and Pelvic Floor Training
General aerobic exercise supports desire through several channels: it lowers cortisol, improves mood, increases blood flow to the genitals, and can improve body image over time. But pelvic floor muscle training deserves its own mention because the evidence is more specific than most people expect. A narrative review found that pelvic floor exercises improve sexual desire, arousal, lubrication, orgasm, and reduce pain during sex across diverse populations of women.18PubMed Central. Female Sexual Function and Pelvic Floor Muscle Training: A Narrative Review The mechanisms include stronger muscle contractions during arousal and orgasm, better blood flow to genital tissue, and psychological benefits like increased body awareness.
For women who experience pain during intercourse, pelvic floor physical therapy involving manual techniques has shown consistent reductions in pain scores across multiple studies.19PubMed Central. The Efficacy of Manual Therapy for Treatment of Dyspareunia in Females: A Systematic Review If pain during sex is part of the picture for you, a pelvic floor physical therapist is worth seeing before assuming the problem is purely about desire. Pain and desire are deeply intertwined: your brain learns to suppress desire for activities that hurt.
Relationship Communication
A meta-analysis looking at how sexual communication relates to sexual satisfaction found a strong positive association, with the quality of communication mattering more than how often couples talked about sex.20PubMed Central. Dimensions of couples’ sexual communication, relationship satisfaction, and sexual satisfaction: A meta-analysis What partners actually said to each other about preferences, boundaries, and what felt good was more predictive of satisfaction than simply having frequent check-ins.
This matters for desire because sexual satisfaction and desire influence each other in a feedback loop. If past sexual encounters have been unsatisfying, your brain has less reason to generate desire for future ones. Couples who communicate well about sex tend to have more satisfying encounters, which gives the brain positive associations to draw on. If you notice that your desire is lower specifically for partnered sex but your interest in fantasy or solo arousal is intact, the relationship context is the first place to look. That’s not blame; it’s information about where the brake is being applied.
Postpartum and Breastfeeding
The postpartum period creates a perfect storm for low desire. Breastfeeding elevates prolactin and suppresses estrogen, which directly reduces both libido and vaginal lubrication.21PubMed Central. Sexual function in breastfeeding women: a systematic review Add sleep deprivation, the physical recovery from birth, identity shifts, and the constant sensory demands of feeding an infant, and desire often drops to near zero. This is physiologically normal and expected. It does not mean something is wrong with you or your relationship.
What helps during this period is mostly practical: using lubricant generously, communicating with your partner about what feels good in a changed body, keeping physical intimacy alive in non-intercourse forms if penetrative sex is uncomfortable, and being patient. Desire typically begins recovering as breastfeeding frequency decreases and estrogen levels rise. If it hasn’t returned well after weaning and sleep has normalized, the other strategies in this article become more relevant.
Supplements and Botanicals
The supplement market for female libido is enormous and largely unregulated, so the evidence bar matters here more than usual. Ashwagandha is one of the few botanicals with a placebo-controlled trial behind it. A pilot study found that women taking ashwagandha root extract showed improvements in arousal, lubrication, orgasm, and satisfaction compared to placebo, along with an increase in successful sexual encounters.22PubMed Central. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Improving Sexual Function in Women: A Pilot Study However, “pilot study” is key: the sample was small, and the results haven’t been replicated in larger trials. Ashwagandha is generally well-tolerated, so trying it isn’t unreasonable, but expecting dramatic results based on one small study isn’t warranted either.
For most other supplements marketed for female libido, including maca, fenugreek, tribulus, and various herbal blends, the evidence is either nonexistent, limited to animal studies, or comes from trials too small and poorly designed to draw conclusions from. The supplement that probably has the strongest indirect evidence is plain magnesium or a vitamin D supplement if you’re deficient, since deficiencies in either can worsen fatigue, mood, and hormonal balance. But these are correcting a deficiency, not boosting desire above baseline.
Cannabis and Desire
Cannabis deserves mention because many women report anecdotally that it helps with arousal, and researchers have started taking the question seriously. A review of the evidence on cannabinoids and female sexual function found dose-dependent effects: low doses generally facilitated or had no effect on desire, while high doses inhibited it.23PubMed. Effects of Cannabinoids on Female Sexual Function The mechanism likely involves reduced anxiety and increased sensory awareness at lower doses, with sedation and cognitive impairment taking over at higher ones.
This is still early-stage science with no randomized controlled trials of the kind that testosterone or flibanserin have undergone. Cannabis is also subject to widely varying legal status and comes with its own side-effect profile. But for women who already use cannabis and have noticed a dose-dependent relationship with their desire, the research at least suggests they’re not imagining it. The practical takeaway, if you choose to explore this, is that less appears to be more.
Putting the Pieces Together Practically
The biggest mistake women make when trying to increase their desire is reaching for a single solution, usually a pill or supplement, without first asking what’s suppressing desire in the first place. The research consistently shows that female sexual desire sits at the intersection of biology, psychology, and relationship context. A woman whose low desire stems from SSRI use needs a medication adjustment, not mindfulness training. A woman whose desire dropped after starting the pill needs a contraception conversation, not testosterone. A woman who is chronically sleep-deprived and stressed may find that no pharmaceutical in the world overcomes what her cortisol levels are doing.
Start by mapping which brakes are engaged. Are you on medications known to suppress desire? Is sex painful? Are you sleeping enough? Is chronic stress dominating your nervous system? Do negative body thoughts intrude during sexual situations? Is your relationship satisfying outside the bedroom? Each of these has a specific, evidence-backed intervention. The women who see the biggest improvements tend to be the ones who identify and address two or three contributing factors simultaneously rather than pinning everything on one magic fix.